Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NTUS

Natus Medical (NTUS) Stock Price, News & Analysis

Natus Medical logo

About Natus Medical Stock (NASDAQ:NTUS)

Advanced Chart

Key Stats

Today's Range
$32.96
$32.96
50-Day Range
$32.96
$32.96
52-Week Range
$20.90
$33.93
Volume
1,514 shs
Average Volume
325,002 shs
Market Capitalization
$1.14 billion
P/E Ratio
89.08
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.

Receive NTUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Natus Medical and its competitors with MarketBeat's FREE daily newsletter.

NTUS Stock News Headlines

Trump’s Wealth Reset: Could You Be The First Beneficiary?
Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real wealth for early adopters In 1933, Executive Order 6102 forced everyday Americans to hand over their gold at a fixed rate. Everyday citizens lost a sizable amount of their hard earned wealth at the stroke of FDR's pen.
See More Headlines

NTUS Stock Analysis - Frequently Asked Questions

Natus Medical Incorporated (NASDAQ:NTUS) issued its earnings results on Thursday, November, 4th. The company reported $0.28 EPS for the quarter, missing the consensus estimate of $0.30 by $0.02. The firm earned $113.88 million during the quarter, compared to the consensus estimate of $116.60 million. Natus Medical had a net margin of 2.65% and a trailing twelve-month return on equity of 10.15%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Natus Medical investors own include Tesla (TSLA), Garmin (GRMN), Zoom Video Communications (ZM), Meta Platforms (META), M&T Bank (MTB), ServiceNow (NOW) and Piper Sandler Companies (PIPR).

Company Calendar

Last Earnings
11/04/2021
Today
6/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:NTUS
Employees
1,400
Year Founded
N/A

Profitability

Trailing P/E Ratio
89.08
Forward P/E Ratio
22.89
P/E Growth
N/A
Net Income
$13.18 million
Pretax Margin
4.15%

Debt

Sales & Book Value

Annual Sales
$473.44 million
Cash Flow
$2.02 per share
Price / Cash Flow
16.34
Book Value
$12.44 per share
Price / Book
2.65

Miscellaneous

Free Float
34,166,000
Market Cap
$1.14 billion
Optionable
Optionable
Beta
0.22
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:NTUS) was last updated on 6/7/2025 by MarketBeat.com Staff
From Our Partners